NIMI
NBIX icon

Natixis Investment Managers International’s Neurocrine Biosciences NBIX Stock Holding History

Natixis Investment Managers International’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,573
Closed -$102K – 440
2015
Q3 		$102K Hold
2,573
– – 0.01% 385
2015
Q2 		$123K Sell
2,573
-2,811
-52% -$119K 0.02% 334
2015
Q1 		$214K Sell
5,384
-3,272
-38% -$117K 0.03% 296
2014
Q4 		$193K Sell
8,656
-25,757
-75% -$488K 0.03% 259
2014
Q3 		$539K Hold
34,413
– – 0.08% 132
2014
Q2 		$511K Sell
34,413
-20,000
-37% -$282K 0.07% 147
2014
Q1 		$876K Buy
+54,413
New +$931K 0.12% 99

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Natixis Investment Managers International's NBIX Position: Q4 2015 in Review

Natixis Investment Managers International sold out of Neurocrine Biosciences (NBIX) in Q4 2015, closing a stake of 2,573 shares — an estimated $102K sold.

Natixis Investment Managers International first reported a position in NBIX in Q1 2014 and held it in 7 quarters. The position peaked at $876K in Q1 2014. 219 funds tracked by Wall St. Rank hold NBIX as of Q4 2015.

  • Natixis Investment Managers International reported no remaining Neurocrine Biosciences position as of Q4 2015 after selling out during the quarter.
  • Natixis Investment Managers International sold 2,573 Neurocrine Biosciences shares in Q4 2015, an estimated $102K.
  • Natixis Investment Managers International first reported a position in Neurocrine Biosciences in Q1 2014 and held it in 7 quarters.
  • Natixis Investment Managers International's Neurocrine Biosciences position peaked at $876K in Q1 2014.
  • 219 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2015.

Based on Natixis Investment Managers International's 13F filing for Q4 2015, filed 16 Feb 2016.